Publication mapping tracks glutamate research in Parkinson's disease
A bibliometric analysis found rising but uneven publication activity, with alpha-synuclein and neuroinflammation emerging as prominent recent research themes.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The analysis mapped how Parkinson's research involving glutamate has developed, identifying increasing publication activity and shifts in prominent topics. Recent attention centered on alpha-synuclein and neuroinflammation. These results describe what researchers publish and cite; they do not demonstrate that a glutamate-focused treatment improves symptoms or changes the course of Parkinson's disease.
The publication set came from Web of Science, so the map reflects that database's coverage. Bibliometric prominence measures research activity and attention, rather than the strength of evidence for a clinical claim.
Where research activity clustered
The United States was identified as a leading contributor, with international collaborations involving several other countries. Karolinska Institute was the most active institution. These findings describe participation in the literature, rather than patient outcomes or clinical performance.
What the topic map captured
Frequently appearing terms included glutamate receptors, oxidative stress, dopamine and synaptic plasticity. The newer prominence of alpha-synuclein and neuroinflammation signals growing research attention, but a topic's visibility does not establish that its proposed mechanisms are correct.
The original publication
Glutamate-associated research in Parkinson's disease: a bibliometric analysis.
Chen YJ, Xie MR, Zhou SQ et al.
Front Aging Neurosci · 2025
- PubMed ID
- 40900991
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.